Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSThis report features data from millions of emails sent to healthcare professionals (HCPs) in 2021 by pharmaceutical brands, hospitals and health systems, and other organizations dedicated to healthcare. Here we provide healthcare marketers with benchmarks, insights, and key learnings to guide their planning and execution of email marketing in the year ahead and beyond.
The analysis draws from IQVIA's True Identity database, the only database of first-party sourced, opted-in, and data privacy compliant HCP identity data. This database also includes records of the digital engagement (web and email) for all participating HCPs.
For this report, email data from January 1 to December 31, 2021 was analyzed, covering 154 million emails sent to U.S.-based physicians on behalf of healthcare brands. This analysis also includes a deeper dive into the email performance of the top three therapeutic specialties engaged with in 2021. With data for 27 medical specialties and 114 subspecialties, IQVIA can provide additional analyses to meet your needs. Read the report to learn more or contact IQVIA if you would like a custom analysis on a specific therapeutic area.
Leveraging Information to Drive Commercial Success
OneKey provides real-time quality HCP and HCO data, thru a variety of delivery options with unique identifiers making it easy to connect to all other IQVIA data sets. OneKey is a solid foundation to build all data assets upon.